SCA
FURX

SAC Capital Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

SAC Capital Advisors’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-83,700
Closed -$7.28M – 1614
2014
Q1 		$7.28M Buy
+83,700
New +$6.46M 0.04% 481

Other funds holding FURX

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SAC Capital Advisors's FURX Position: Q2 2014 in Review

SAC Capital Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q2 2014, closing a stake of 83,700 shares — an estimated $7.28M sold.

SAC Capital Advisors first reported a position in FURX in Q1 2014 and held it in 1 quarter. The position peaked at $7.28M in Q1 2014. 102 funds tracked by Wall St. Rank hold FURX as of Q2 2014.

  • SAC Capital Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 83,700 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $7.28M.
  • SAC Capital Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • SAC Capital Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $7.28M in Q1 2014.
  • 102 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.